Mechanism by which Etanercept inhibits LPS-induced embryo loss

SHI Li-juan,LI Li-ping,ZHANG Xu-miao,REN Jia-bin,QIN Xiao-li,LIN Yi
2013-01-01
Abstract:It is known that Toll-like receptor 4(TLR4)specifically interacts with LPS and mediates immune response against bacteria.In the current study,it was found that the percentage of embryo loss was significantly boosted in response to lipopolysaccharide(LPS)induction in a dose-dependent manner.In addition,ipinjection of Etanercept at a dose of 5mg/kg body weight almost completely abrogated the effect of LPS on murine embryo loss(30.6%vs 6.0%;P<0.01).In flow cytometry,LPS-induced increase in the proportion F4/80+TNF-α+cells in F4/80+cell population was abolished by Etanercept administration at the indicated dosage(26.4%vs 4.7%;P<0.01).In comparison,no significant change was observed in the proportion of F4/80+IL-10+cells in F4/80+cell population among control PBS group,LPS-treated group and the group treated with LPS and Etanercept.The findings indicate that Etanercept may prevent LPS-induced abortion by inhibition on F4/80+TNF-α+cells.
What problem does this paper attempt to address?